Skip to main content
Year archive

HIKMA Pharmaceuticals PLC — 2023 filings

All 45 regulatory filings released by HIKMA Pharmaceuticals PLC (HIK) in 2023, sourced directly from the official regulator.

45 Filings
2023 Period
2023 filings (45)
Filing Released Lang
Company Secretary Change
Board/Management Information
2023-12-29 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-12-01 English
Trading Statement
Earnings Release FY 2023
2023-11-02 English
Block listing Interim Review
Share Issue/Capital Change
2023-10-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-10-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-09-01 English
Director/PDMR Shareholding
Remuneration Information
2023-08-31 English
Director/PDMR Shareholding
Remuneration Information
2023-08-11 English
Director/PDMR Shareholding
Director's Dealing
2023-08-10 English
Hikma appoints new President of Injectables
Board/Management Information
2023-08-09 English
Half-year Report
Earnings Release H1 2023
2023-08-03 English
Notice of Results
Report Publication Announcement
2023-07-17 English
Holding(s) in Company
Major Shareholding Notification
2023-06-14 English
Director/PDMR Shareholding
Director's Dealing
2023-06-08 English
Director/PDMR Shareholding
Director's Dealing
2023-05-31 English
Group of companies' accounts made up to 2022-12-31
Regulatory Filings
2023-05-31 English
Holding(s) in Company
Major Shareholding Notification
2023-05-23 English
Director/PDMR Shareholding
Director's Dealing
2023-05-17 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-05-02 English
Result of AGM
AGM Information
2023-04-28 English
Special Resolutions passed at AGM
AGM Information
2023-04-28 English
Trading Statement
Earnings Release FY 2022
2023-04-28 English
Director/PDMR Shareholding
Director's Dealing
2023-04-24 English
Directorate Change
Board/Management Information
2023-04-12 English
Block listing Interim Review
Remuneration Information
2023-04-03 English
Total Voting Rights
Share Issue/Capital Change
2023-04-03 English
Annual Financial Report and Notice of AGM
Report Publication Announcement
2023-03-16 English
Annual Report and Accounts
Annual Report FY 2022
2023-03-16 English
Annual Report and Accounts
Annual Report FY 2022
2023-03-16 English
Deferred Bonus Plan Rules
Remuneration Information
2023-03-16 English
Long-term Incentive Plan Rules
Remuneration Information
2023-03-16 English
Annual Report and Accounts
Annual Report FY 2022
2023-03-16 English
Annual General Meeting Notice of Meeting
AGM Information
2023-03-16 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-03-02 English
Final Results
Earnings Release FY 2022
2023-02-23 English
Holding(s) in Company
Major Shareholding Notification
2023-02-17 English
Notice of Results
Report Publication Announcement
2023-02-07 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-02-01 English
Director/PDMR Shareholding
Director's Dealing
2023-01-18 English
Holding(s) in Company
Major Shareholding Notification
2023-01-18 English
Holding(s) in Company
Major Shareholding Notification
2023-01-17 English
Additional Listing
Share Issue/Capital Change
2023-01-10 English
Director/PDMR Shareholding
Director's Dealing
2023-01-10 English
Total Voting Rights
Share Issue/Capital Change
2023-01-03 English
Hikma launches sodium oxybate in the US
Regulatory Filings
2023-01-03 English